National Research (NRC) Competitors $18.50 +0.34 (+1.87%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NRC vs. OABI, ABSI, MXCT, PGEN, LUNA, NOTV, ONMD, PIRS, BIAF, and AIKIShould you be buying National Research stock or one of its competitors? The main competitors of National Research include OmniAb (OABI), Absci (ABSI), MaxCyte (MXCT), Precigen (PGEN), Luna Innovations (LUNA), Inotiv (NOTV), OneMedNet (ONMD), Pieris Pharmaceuticals (PIRS), bioAffinity Technologies (BIAF), and AIkido Pharma (AIKI). National Research vs. OmniAb Absci MaxCyte Precigen Luna Innovations Inotiv OneMedNet Pieris Pharmaceuticals bioAffinity Technologies AIkido Pharma National Research (NASDAQ:NRC) and OmniAb (NASDAQ:OABI) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, community ranking, valuation and risk. Which has stronger earnings & valuation, NRC or OABI? National Research has higher revenue and earnings than OmniAb. OmniAb is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational Research$148.58M2.96$30.97M$1.1316.31OmniAb$21.71M23.51-$50.62M-$0.62-6.97 Do analysts rate NRC or OABI? OmniAb has a consensus target price of $9.00, suggesting a potential upside of 107.85%. Given OmniAb's higher possible upside, analysts plainly believe OmniAb is more favorable than National Research.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National Research 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AOmniAb 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, NRC or OABI? National Research has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, OmniAb has a beta of -0.12, meaning that its stock price is 112% less volatile than the S&P 500. Does the MarketBeat Community favor NRC or OABI? National Research received 90 more outperform votes than OmniAb when rated by MarketBeat users. However, 100.00% of users gave OmniAb an outperform vote while only 61.67% of users gave National Research an outperform vote. CompanyUnderperformOutperformNational ResearchOutperform Votes11161.67% Underperform Votes6938.33% OmniAbOutperform Votes21100.00% Underperform VotesNo Votes Do institutionals & insiders hold more shares of NRC or OABI? 47.3% of National Research shares are held by institutional investors. Comparatively, 72.1% of OmniAb shares are held by institutional investors. 2.0% of National Research shares are held by insiders. Comparatively, 8.6% of OmniAb shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to NRC or OABI? In the previous week, National Research had 3 more articles in the media than OmniAb. MarketBeat recorded 4 mentions for National Research and 1 mentions for OmniAb. OmniAb's average media sentiment score of 0.89 beat National Research's score of 0.19 indicating that OmniAb is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Research 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OmniAb 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is NRC or OABI more profitable? National Research has a net margin of 18.78% compared to OmniAb's net margin of -287.29%. National Research's return on equity of 64.43% beat OmniAb's return on equity.Company Net Margins Return on Equity Return on Assets National Research18.78% 64.43% 22.41% OmniAb -287.29%-20.21%-17.13% SummaryNational Research beats OmniAb on 10 of the 17 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get National Research News Delivered to You Automatically Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRC vs. The Competition Export to ExcelMetricNational ResearchCommercial physical research IndustryBusiness SectorNASDAQ ExchangeMarket Cap$439.92M$4.62B$6.16B$8.42BDividend Yield2.65%1.70%3.00%4.16%P/E Ratio16.3147.2341.6816.66Price / Sales2.96118.32159.7079.42Price / Cash11.9123.4324.4633.53Price / Book9.122.894.505.19Net Income$30.97M$133.52M$114.21M$223.67M7 Day Performance-1.81%45.17%-1.37%2.63%1 Month Performance-7.71%62.79%-0.51%8.69%1 Year Performance-55.76%46.56%31.20%28.41% National Research Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRCNational Research1.9748 of 5 stars$18.50+1.9%N/A-55.6%$441.60M$148.58M16.37435OABIOmniAb2.1303 of 5 stars$4.18+2.2%$9.00+115.3%-7.9%$493.91M$34.16M-6.747Upcoming EarningsABSIAbsci1.7591 of 5 stars$3.92+2.1%$8.67+121.1%+181.7%$445.16M$5.72M-4.22210Upcoming EarningsMXCTMaxCyte2.8385 of 5 stars$3.77+5.3%$8.67+129.9%+9.9%$396.49M$41.29M-11.09143Upcoming EarningsNews CoveragePGENPrecigen4.2222 of 5 stars$0.82+3.8%$7.00+757.0%-32.8%$206.45M$6.22M-1.51202Positive NewsLUNALuna Innovations2.1654 of 5 stars$1.66+7.1%$8.00+381.9%-74.9%$56.37M$116.61M-20.75337Upcoming EarningsNOTVInotiv1.6534 of 5 stars$1.78+0.6%$5.92+232.4%-3.3%$46.28M$572.42M-0.462,055Positive NewsONMDOneMedNetN/A$0.81-5.8%N/AN/A$25.50M$1.02M0.002Gap DownPIRSPieris Pharmaceuticals2.3297 of 5 stars$17.30+0.3%N/A-18.6%$22.84M$20.87M-0.92140Upcoming EarningsBIAFbioAffinity Technologies2.2379 of 5 stars$1.37-4.2%$6.00+338.0%-2.3%$18.40M$2.53M-1.4910Upcoming EarningsPositive NewsAIKIAIkido PharmaN/A$1.69-0.6%N/A+77.1%$9.24M$10,000.00-0.434 Related Companies and Tools Related Companies OABI Alternatives ABSI Alternatives MXCT Alternatives PGEN Alternatives LUNA Alternatives NOTV Alternatives ONMD Alternatives PIRS Alternatives BIAF Alternatives AIKI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NRC) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRC Stock Alerts